Huaren Pharmaceutical Co., Ltd. (300110.SZ)
CNY 2.9
(3.2%)
CNY 2.9
(3.2%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 469.88 Million CNY | 0.04% |
| 2022 | 392.92 Million CNY | -18.51% |
| 2021 | 482.15 Million CNY | 24.25% |
| 2020 | 388.04 Million CNY | -41.79% |
| 2019 | 666.66 Million CNY | -3.33% |
| 2018 | 689.6 Million CNY | 24.18% |
| 2017 | 555.32 Million CNY | 21.27% |
| 2016 | 457.93 Million CNY | 16.22% |
| 2015 | 394.01 Million CNY | 18.84% |
| 2014 | 331.54 Million CNY | 15.76% |
| 2013 | 286.39 Million CNY | 46.57% |
| 2012 | 195.4 Million CNY | 44.52% |
| 2011 | 135.2 Million CNY | 40.23% |
| 2010 | 96.41 Million CNY | 29.42% |
| 2009 | 74.5 Million CNY | 58.22% |
| 2008 | 47.08 Million CNY | 94.56% |
| 2007 | 24.2 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 79.69 Million CNY | -14.52% |
| 2024 Q3 | 51.47 Million CNY | -14.97% |
| 2024 Q1 | 93.22 Million CNY | -4.85% |
| 2023 Q3 | 88.88 Million CNY | -17.29% |
| 2023 Q4 | 97.97 Million CNY | 10.23% |
| 2023 FY | 393.07 Million CNY | 0.04% |
| 2023 Q1 | 98.74 Million CNY | -9.8% |
| 2023 Q2 | 107.46 Million CNY | 8.83% |
| 2022 FY | 392.92 Million CNY | -18.51% |
| 2022 Q2 | 54.32 Million CNY | -58.16% |
| 2022 Q3 | 99.28 Million CNY | 82.77% |
| 2022 Q4 | 109.47 Million CNY | 10.26% |
| 2022 Q1 | 129.82 Million CNY | -13.36% |
| 2021 Q3 | 119.49 Million CNY | 27.91% |
| 2021 FY | 482.15 Million CNY | 24.25% |
| 2021 Q1 | 119.38 Million CNY | 300.28% |
| 2021 Q2 | 93.42 Million CNY | -21.75% |
| 2021 Q4 | 149.85 Million CNY | 25.4% |
| 2020 FY | 388.04 Million CNY | -41.79% |
| 2020 Q3 | 132.54 Million CNY | 18.63% |
| 2020 Q4 | 29.82 Million CNY | -77.5% |
| 2020 Q1 | 113.93 Million CNY | -5.32% |
| 2020 Q2 | 111.73 Million CNY | -1.93% |
| 2019 Q3 | 188.76 Million CNY | 1.08% |
| 2019 FY | 666.66 Million CNY | -3.33% |
| 2019 Q1 | 170.79 Million CNY | -0.33% |
| 2019 Q2 | 186.75 Million CNY | 9.34% |
| 2019 Q4 | 120.34 Million CNY | -36.25% |
| 2018 Q1 | 163.17 Million CNY | 1.81% |
| 2018 FY | 689.6 Million CNY | 24.18% |
| 2018 Q4 | 171.36 Million CNY | -9.78% |
| 2018 Q2 | 165.13 Million CNY | 1.2% |
| 2018 Q3 | 189.93 Million CNY | 15.02% |
| 2017 Q3 | 139.31 Million CNY | 0.57% |
| 2017 Q4 | 160.26 Million CNY | 15.04% |
| 2017 FY | 555.32 Million CNY | 21.27% |
| 2017 Q2 | 138.52 Million CNY | 17.16% |
| 2017 Q1 | 118.23 Million CNY | -11.99% |
| 2016 Q4 | 134.34 Million CNY | 13.49% |
| 2016 Q1 | 90.68 Million CNY | -28.33% |
| 2016 Q2 | 114.53 Million CNY | 26.3% |
| 2016 Q3 | 118.37 Million CNY | 3.35% |
| 2016 FY | 457.93 Million CNY | 16.22% |
| 2015 FY | 394.01 Million CNY | 18.84% |
| 2015 Q2 | 106.88 Million CNY | 33.08% |
| 2015 Q3 | 80.28 Million CNY | -24.88% |
| 2015 Q4 | 126.52 Million CNY | 57.6% |
| 2015 Q1 | 80.31 Million CNY | -20.91% |
| 2014 Q3 | 76.83 Million CNY | -15.25% |
| 2014 Q4 | 101.54 Million CNY | 32.15% |
| 2014 Q1 | 62.49 Million CNY | -34.21% |
| 2014 Q2 | 90.66 Million CNY | 45.06% |
| 2014 FY | 331.54 Million CNY | 15.76% |
| 2013 Q3 | 64.67 Million CNY | -12.25% |
| 2013 Q1 | 53.01 Million CNY | -24.68% |
| 2013 Q4 | 95 Million CNY | 46.9% |
| 2013 FY | 286.39 Million CNY | 46.57% |
| 2013 Q2 | 73.7 Million CNY | 39.01% |
| 2012 Q2 | 45.48 Million CNY | 38.55% |
| 2012 Q4 | 70.38 Million CNY | 50.73% |
| 2012 Q1 | 32.83 Million CNY | -17.55% |
| 2012 FY | 195.4 Million CNY | 44.52% |
| 2012 Q3 | 46.69 Million CNY | 2.66% |
| 2011 FY | 135.2 Million CNY | 40.23% |
| 2011 Q3 | 35.47 Million CNY | 12.7% |
| 2011 Q2 | 31.47 Million CNY | 10.71% |
| 2011 Q4 | 39.82 Million CNY | 12.25% |
| 2011 Q1 | 28.43 Million CNY | 0.44% |
| 2010 FY | 96.41 Million CNY | 29.42% |
| 2010 Q1 | 21.55 Million CNY | -0.02% |
| 2010 Q2 | 24.57 Million CNY | 14.04% |
| 2010 Q3 | 21.98 Million CNY | -10.56% |
| 2010 Q4 | 28.3 Million CNY | 28.77% |
| 2009 Q3 | 19.56 Million CNY | 0.0% |
| 2009 Q4 | 21.55 Million CNY | 10.18% |
| 2009 FY | 74.5 Million CNY | 58.22% |
| 2008 FY | 47.08 Million CNY | 94.56% |
| 2007 FY | 24.2 Million CNY | 0.0% |